Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Abbott Labs Says FDA Clears Leukemia Test

By Pharmaceutical Processing | October 24, 2011

Abbott Laboratories Inc. said Monday that regulators approved a test that helps determine the prognosis of patients with acute myeloid leukemia.

 

The Vysis EGR1 FISH Probe Kit can help physicians determine which patients can be treated with chemotherapy, the first option for AML, and who has more severe disease and may require a stem cell transplant. The test detects a deletion in part of a chromosome that is associated with more severe disease.

 

Abbott said about 12,000 cases of AML are diagnosed per year in the U.S.

 

The Food and Drug Administration has approved three of Abbott’s FISH tests in recent months. Earlier this year the agency gave marketing clearance for a test that can help identify breast cancer patients who can benefit from the drug Herceptin, and another test that helps determine the prognosis of patients with chronic lymphocytic leukemia.

 

Shares of Abbott lost 37 cents to $53.49 in afternoon trading. The company said Wednesday that it plans to split into two companies, separating its branded drug unit from the division that sells nutritional formula, generic drugs and heart stents.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE